Rutherford, NJ, April 13, 2023 GlucoTrack, Inc. , a medical device and digital health platform company focused on diabetes and prediabetes, today announced the pricing of a firm commitment. | April 13, 2023
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) GlucoTrack, Inc. (Nasdaq: GCTK) ("GlucoTrack" or the "Company"), a medical device